To demonstrate that PTEN deletion in the MCF10A cells is a prerequisite to elicit malignant transformation in response to cancer patient serum, maternal MCF10A cells were treated with healthy control (n = 3) or cancer patient sera (n = 3 CRCLM sera) (Supplementary Fig. S2). This evidence concerns the gene PTEN and cancer.